ScoreWhy is Alembic Pharmaceuticals Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate -6.71% of over the last 5 years
2
Flat results in Jun 26
- INTEREST(Q) Highest at Rs 27.61 cr
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 4.11% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -12.69% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Alembic Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Alembic Pharma
-12.69%
-0.47
27.22%
Sensex
-2.63%
-0.19
13.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.68%
EBIT Growth (5y)
-6.71%
EBIT to Interest (avg)
11.07
Debt to EBITDA (avg)
1.02
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.03
Tax Ratio
4.98%
Dividend Payout Ratio
37.06%
Pledged Shares
0
Institutional Holding
20.12%
ROCE (avg)
11.33%
ROE (avg)
10.96%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
37
Price to Book Value
2.87
EV to EBIT
21.22
EV to EBITDA
15.00
EV to Capital Employed
2.54
EV to Sales
2.25
PEG Ratio
0.80
Dividend Yield
1.45%
ROCE (Latest)
11.59%
ROE (Latest)
12.93%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
PAT(Latest six months)
At Rs 400.53 cr has Grown at 28.68%
NET SALES(Q)
Highest at Rs 2,149.77 cr
PBDIT(Q)
Highest at Rs 331.86 cr.
-3What is not working for the Company
INTEREST(Q)
Highest at Rs 27.61 cr
Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Profit After Tax (PAT) - Latest six months
At Rs 400.53 cr has Grown at 28.68%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 2,149.77 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 2,149.77 cr has Grown at 25.66%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 331.86 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Alembic Pharma
Interest - Quarterly
Highest at Rs 27.61 cr
in the last five quarters and Increased by 22.38 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
